## HD: Home Depot, Inc. (The) - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -0.1% below STRENGTH zone (4.0-10.0%); PEG 3.79 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($340.08)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. What's Going On With Home Depot Stock Tuesday? - Home Depot (NYSE:HD)**
- Source: Benzinga | 20251209T131532 | Neutral | Relevance: 99%
-  Home Depot will use its 2025 Investor and Analyst Conference to reaffirm its fiscal 2025 outlook and establish an early baseline for fiscal 2026, including a scenario anticipating a housing-led demand increase. The company reiterated its fiscal 2025 expectations, projecting approximately 3% total sales growth and a 6% diluted EPS decline. For fiscal 2026, Home Depot foresees comparable sales ranging from flat to up 2%, with a "Market Recovery Case" anticipating higher sales and EPS growth driven by an improved housing market.

**2. The Home Depot Provides a Strategic Update; Reaffirms Fiscal 2025 Guidance; Establishes a Preliminary Fiscal 2026 Outlook and a Market Recovery Case**
- Source: The Home Depot | 20251209T111048 | Somewhat-Bullish | Relevance: 99%
-  The Home Depot reaffirmed its fiscal 2025 guidance and provided a preliminary fiscal 2026 outlook. The company also presented a "Market Recovery Case" anticipating accelerated sales and earnings per share growth once housing activity and larger project spending rebound. These updates were discussed at its 2025 Investor and Analyst Conference, emphasizing its strategy to drive core growth, deliver a frictionless experience, and expand its pro customer segment.

**3. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Home Depot, Inc. - HD**
- Source: PR Newswire | 20251211T150232 | Neutral | Relevance: 99%
-  The Pomerantz Law Firm is investigating potential securities fraud claims against The Home Depot, Inc. (NYSE: HD) on behalf of its investors. This investigation follows Home Depot's announcement of Q3 2025 financial results and updated guidance, which reported missed earnings and sales forecasts attributed to external factors and consumer uncertainty. As a result, Home Depot's stock price experienced a significant drop.

**4. Bronstein, Gewirtz & Grossman, LLC Encourages The Home Depot, Inc. (HD) Stockholders to Inquire about Securities Investigation**
- Source: KXAN Austin | 20251210T160747 | Neutral | Relevance: 99%
-  Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Home Depot, Inc. (NYSE: HD) after the company announced missing Q3 2025 sales forecasts, attributing it to a lack of storms and consumer uncertainty. Home Depot's stock price dropped over 6% following this announcement. The firm is encouraging stockholders to inquire about the securities investigation.

**5. Lost Investment in The Home Depot, Inc. (HD)? Levi & Korsinsky Launches Securities Fraud Investigation**
- Source: WIVB News 4 | 20251211T194508 | Neutral | Relevance: 99%
-  Levi & Korsinsky has initiated a securities fraud investigation into The Home Depot, Inc. (HD) following a drop in its stock price. The investigation stems from The Home Depot's announcement of third-quarter fiscal results and updated 2025 guidance, where the CEO disclosed that results missed expectations due to lower-than-anticipated demand, leading to a more than 6% stock price decrease on November 18, 2025. The firm aims to determine if federal securities laws were violated.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 20)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | DA Davidson | $407 | $430 | -5% |
| 2025-12-10 | Wells Fargo | $395 | $400 | -1% |
| 2025-12-10 | UBS | $430 | $445 | -3% |
| 2025-12-10 | RBC Capital | $366 | $376 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | DA Davidson | main | Buy |
| 2025-12-10 | Wells Fargo | main | Overweight |
| 2025-12-10 | UBS | main | Buy |
| 2025-12-10 | RBC Capital | main | Sector Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 9 ($0.86M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.9% (+0.3%)
- Blackrock Inc.: 7.6% (-1.7%)
- State Street Corpora: 4.6% (+0.2%)
- Geode Capital Manage: 2.4% (+1.9%)
- Morgan Stanley: 2.3% (-0.4%)

### Key Risks

1. Valuation stretched: PEG 3.8x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.79 signals overvaluation risk, limited margin of safety. Forward P/E 23.5x stretched relative to 5% growth. Quality metrics strong (ROE 163%, ROA 13%). Balance sheet: $3.1B free cash flow. Analyst sentiment negative (20 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $355.9B |
| Beta | 1.05 |
| 52W Range | $326.31 - $426.75 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.79 |
| Forward P/E | 23.5 |
| Current P/E | 24.5 |
| YoY Growth | 4.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -2.2% to -0.1% (+2.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.1pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.6%) - potential reversal signal. Below SMA200 (0.95x), long-term trend not supportive. MACD histogram positive (1.74), confirming momentum. RSI neutral at 49.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.14% (CS: 45) | Neutral |
| RSI_14 | 49.4 | Neutral |
| MACD Histogram | 1.74 | Bullish |
| vs SMA20 | 1.019x | Above |
| vs SMA50 | 0.967x | Below |
| vs SMA200 | 0.954x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $357.46
- **Stop Loss:** $340.08 (4.9% risk)
- **Target:** $374.84 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 79
- **Position Value:** $28,239.34
- **Portfolio %:** 28.24%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-24 (Est: $3.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $3.83 | $3.74 | -2.5% |
| 2025Q3 | $4.69 | $4.68 | -0.3% |
| 2025Q2 | $3.59 | $3.56 | -0.8% |
| 2025Q1 | $3.04 | $3.02 | -0.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*